
NEOCHEM
Neochem Bio Solutions Limited
- IPO Status
- Closed
- Open Date
- 2 Dec 2025
- Close Date
- 4 Dec 2025
IPO Details
- Min. Investment
- ₹2,35,200
- Price Band
- ₹93 - ₹98
- Lot Size
- 1200 shares
- Issue Size
- ₹45 Cr
- Face Value
- 10
- IPO Doc
- —
Schedule
- IPO open2 Dec 2025
- IPO close date4 Dec 2025
- Allotment date5 Dec 2025
- Funds unblock or debit8 Dec 2025
- Listing date9 Dec 2025
Financial Performance
- Revenue
- Profit
Stocks similar to NEOCHEM
- Rossari Biotech Limited
FAQs
Neochem Bio Solutions Limited IPO is a SME IPO aggregating up to ₹45 Cr, with equity shares of face value ₹10 each. The shares are proposed to be listed on NSE.
The Neochem Bio Solutions Limited IPO opened on 2 Dec 2025 and closed on 4 Dec 2025. IPO Period: 2 Dec 2025 – 4 Dec 2025.
The price band for the Neochem Bio Solutions Limited IPO is ₹93 to ₹98 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 1,200 shares. At the upper price band of ₹98, the minimum investment required is ₹2,35,200.
Particular Details Lot Size 1,200 shares Minimum Application 2,400 shares Price Band ₹93 – ₹98 Minimum Investment ₹2,35,200 Here is the timeline for the Neochem Bio Solutions Limited IPO:
IPO Event Date IPO Opens 2 Dec 2025 IPO Closes 4 Dec 2025 UPI Mandate Deadline 4 Dec 2025, 5:00 PM Basis of Allotment 5 Dec 2025 Refund Initiation 8 Dec 2025 Shares Credited 8 Dec 2025 Listing Date 9 Dec 2025 The basis of allotment for the Neochem Bio Solutions Limited IPO is expected to be finalised on 5 Dec 2025. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: Link Intime.
The equity shares of Neochem Bio Solutions Limited are proposed to be listed on NSE. Proposed Listing Date: 9 Dec 2025.
The key financial performance of Neochem Bio Solutions Limited is:
Financial Year Revenue Profit FY24 ₹61.15 Cr ₹1.93 Cr FY25 ₹84.17 Cr ₹7.44 Cr FY26 ₹110.7 Cr ₹12.03 Cr Revenue CAGR: 34.5% | Profit CAGR: 149.7%. Figures are as disclosed in the company's offer documents.


